Inspur Software Co Ltd

600756.CG▼

Inspur Software narrows first-half 2026 net loss by 5.46 million yuan year on year

Inspur Software disclosed its 2026 semi-annual report on August 26. In the first half, total operating revenue reached 445 million yuan, up 3.75 percent year on year. Net loss attributable to the parent company was 142 million yuan, compared with a loss of 148 million yuan in the same period last year, narrowing the loss by 5.46 million yuan. Net loss after deducting non-recurring items was 143 million yuan, compared with 148 million yuan a year earlier. Net cash flow from operating activities was negative 205 million yuan, versus negative 208 million yuan in the prior-year period. Basic loss per share was 0.41 yuan, and the weighted average return on equity was negative 6.33 percent, up 0.23 percentage point year on year. As of the end of the first half, the company's cash and cash equivalents fell 35.2 percent from the end of last year, and inventory book value stood at 539 million yuan, accounting for 24.76 percent of net assets.

600756.CG ▼

中国证券报·1dRead more ▾

600756.CG▼

Inspur Software's 2026 interim report shows net loss of 142 million yuan, narrowing year-on-year

Inspur Software released its 2026 interim report, with total operating revenue of 445 million yuan, up 3.75% year-on-year, and net profit attributable to the parent company of negative 142 million yuan, an improvement of 5.4625 million yuan compared with the same period last year, with the loss narrowing. Net cash flow from operating activities was negative 205 million yuan, improving for two consecutive years. The company's asset-liability ratio was 45.91%, gross margin was 40.74%, return on equity was negative 6.53%, and diluted earnings per share was negative 0.41 yuan. The number of shareholders was 67,200, and the top ten shareholders held 31.27% of the total share capital.

600756.CG ▼

Jiemian·1dRead more ▾

600756.CG▼

Inspur Software first-half revenue 445 million yuan, loss narrows to 142 million yuan

Inspur Software released its 2026 interim report. First-half operating revenue was 445 million yuan, up 3.7 percent year on year. Net loss attributable to the parent was 142 million yuan, narrowing from a loss of 148 million yuan in the same period last year. Second-quarter operating revenue was 312 million yuan, down 3.3 percent year on year, and net loss attributable to the parent was 56.09 million yuan, smaller than the 59.39 million yuan loss a year earlier. As of the end of the second quarter, total assets were 4.044 billion yuan, down 7.4 percent from the end of last year, and net assets attributable to the parent were 2.179 billion yuan, down 6.1 percent from the end of last year. The company said revenue growth was mainly driven by higher income in digital government and e-commerce, and it will continue to strengthen cooperation with government and enterprise clients across regions to advance digital and intelligent transformation.

600756.CG ▼

财中社·2dRead more ▾

600756.CG▲

A-share pharmaceutical sector surges in afternoon trading, Guoxin Health and others hit daily limit up

Today, the pharmaceutical sector in the A-share market was active, with the DRG/DIP sub-sector leading gains. ST Rongke hit the 20 percent daily limit up, while Inspur Software, Saili Medical, and Guoxin Health also reached their daily limit up. In terms of news, the National Administration of Traditional Chinese Medicine and 10 other departments jointly issued the Action Plan for the Traditional Chinese Medicine Component of the Medical and Health Foundation Strengthening Project, aiming to enhance the supply of traditional Chinese medicine services at the grassroots level. About one minute after the afternoon session opened, Guoxin Health surged straight to its daily limit up, with its stock price reaching 7.17 yuan per share and its latest market capitalization at 7.021 billion yuan. Guoxin Health primarily engages in comprehensive medical insurance management services, offering DRG, DIP, and other diversified payment method services to medical insurance clients, and leveraging AI technology to provide solutions for medical institutions and disease control departments.

000503.CS ▲600756.CG ▲603716.CG ▲

市场行情·30dRead more ▾